Join Lachman Consultant Services, Inc. (Lachman Consultants) at the GRx+Biosims 2021 virtual event for three days of timely insights, peer networking, and unique content geared toward technical, regulatory, and policy professionals in the U.S. generics and biosimilars industry. Held from November 8 – 10, the widely acclaimed event will bring together top officials and subject-matter experts who will share their knowledge and best practices to help attendees better understand how to succeed in generic and biosimilar development, the regulatory process, and the evolving policy landscape.
As a leading provider of technical and regulatory consultation services for the pharmaceutical, biotechnology, biologics, diagnostic, device, and allied health industries, Lachman Consultants is proud to be hosting a virtual booth at this year’s interactive event. Drop in, shake some virtual hands, and learn more about the latest trends in the industry.
While there, be sure to tune into the Association for Accessible Medicines (AAM) All Access Podcast special, featuring Lachman Consultants’ Senior Advisor Bob Pollock. During the one-hour podcast, AAM CEO Dan Leonard will interview Bob about his experience working at the FDA’s Office of Generic Drugs, and early challenges faced by an embryonic industry that has grown to become the backbone of today’s pharmaceutical business.
Complete with keynotes, panel discussions, and networking opportunities, the virtual experience will serve as a one-stop-shop to help attendees meet their regulatory and scientific needs related to generics and biosimilars. Don’t miss this tremendous opportunity to hear more about what’s going on in the industry, learn how the industry is driving positive patient outcomes, and get the latest on regulations, guidance, case law, and policies.
The AAM All Access Podcast special will air on November 8 at 10:00 am EST here. To register for this event, click here.